Reby Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Reby Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$51K	Buy	+109	New	+$51.1K	0.01%	224

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Reby Advisors's TMO Position: Q4 2020 in Review

Reby Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q4 2020: 109 shares worth $51K. The stake represents 0.01% of the portfolio and ranks #224 among its holdings.

2,030 funds tracked by Wall St. Rank hold TMO as of Q4 2020.

Reby Advisors held 109 shares of Thermo Fisher Scientific worth $51K as of Q4 2020.
Thermo Fisher Scientific was a new Reby Advisors position in Q4 2020.
Thermo Fisher Scientific made up 0.01% of Reby Advisors's portfolio in Q4 2020, its #224 holding.
2,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2020.

Based on Reby Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.